Practice-Based Recommendations for the Management of RR/MDR-TB

by Lindsay McKenna

Dear Colleagues: Attached and below please find a statement from DR-TB STAT and Treatment Action Group outlining practice-based recommendations for the optimal management of RR/MDR-TB. We hope this practical advice will help country programs implement the 2018 WHO recommendations for the management of RR/MDR-TB. Thank you for all you are ... read more

Updated: 21 Aug, 2019
Replies: 0

Now available: List of countries eligible for bedaquiline $400 price

by Erica Lessem

*Apologies for cross-posting* Many of you may be aware that last year, Janssen announced a price reduction for its drug-resistant TB medicine, bedaquiline, to USD $400 for a six-month course. Now, finally, the list of countries eligible to access that price is available: http://www.stoptb.org/gdf/ drugsupply/bedaquiline.asp The good news is the ... read more

Updated: 18 Aug, 2019
Replies: 0

Treatment Action Group's Statement on U.S. FDA Approval of Pretomanid

SOPHAN SAM replied

Thank for sharing the approved new drug for more option to treat MDRTB patients. read more

Updated: 15 Aug, 2019
Replies: 2

Applications open for 2020 Advocacy Fellows program [AVAC]

by Erica Lessem

*Apologies for cross-posting* Please see this exciting opportunity. I do not have additional information about this; for questions or to apply, please contact AVAC directly per instructions below. ---------- Forwarded message --------- Problems viewing this newsletter? View it in your browser > <https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fmailchi.mp%2favac%2fushering-in-the-next-decade-of-the-fellows-program-apply-now-to-become-a-2020-fellow%3fe%3de099b92a9b&c=E,1,QRorBND5R7T4u3u5ojnacnwUTaDHkDceGnC4DyTnb2tyI4k5aED-Mxqb5IsU7QVhfV9P_eqjJfHMZhXlUqFdUF_C_FdsQZj3AXFCh-KgYOMxQdwTXQ,,&typo=0> Apply Now to Become a 2020 Fellow ... read more

Updated: 09 Aug, 2019
Replies: 0

Application to ENGAGE-TB Regional Workshop (Latin America and the Caribbean)

by Daniel Bernal

Partners in Health together with the TB Coalition of the Americas are pleased to invite members of the Civil Society from El Salvador, Guatemala and Mexico to apply to participate in the 1st Regional Workshop for Socialization and Awareness of the WHO ENGAGE-TB approach. This workshop will take place from ... read more

Updated: 07 Aug, 2019
Replies: 0

Fwd: Public call for individual patient data on treatment of drug-resistant tuberculosis

by Erica Lessem

Apologies for cross-posting-- Please see this call from WHO for individual patient data on drug-resistant TB treatment outcomes. The more data the WHO receives, the more data-driven and useful their recommendations can be. Please contribute data to this effort or forward to someone who can ! Thank you, Erica ---------- ... read more

Updated: 01 Aug, 2019
Replies: 0


Regina Bhebhe replied

Thank you for the information ,I hope this it is genuine. read more

Updated: 27 Jul, 2019
Reply: 1

Shorter MDR TB regimen

Dr. Saswata Dutt replied

Thank you so much Dr. Tom. Yes, I cannot agree more with you and the articles. I have seen one of them before. The challenge is - the 'disease TB' probably does not have the same luxury footing as 'disease HIV' or 'disease HCV'!! Without international donor support, most of ... read more

Updated: 26 Jul, 2019
Replies: 12


by Sharonann Lynch

[Please share with your networks] NOW HIRING: A TB ADVOCACY ADVISOR WITH THE MSF ACCESS CAMPAIGN MSF ACCESS CAMPAIGN TB ADVOCACY ADVISOR Contract: Full-time, fixed-term Duration: 2 years, with possibility of extension Starting date: ASAP Location: MSF headquarter offices in the U.S., Europe, South Africa, or other locations can be ... read more

Updated: 24 Jul, 2019
Replies: 0